ArticleFrontiers in immunology2022

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.

Fu-Xue Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.